QQ客服 官方微博 反馈留言

	Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection
	Yang, Guo-Huan; Fan, Jia; Xu, Yang; Qiu, Shuang-Jian; Yang, Xin-Rong; Shi, Guo-Ming; Wu, Bing; Dai, Zhi; Liu, Yin-Kun; Tang, Zhao-You
刊名	ONCOLOGIST
	2008
卷号	13期号:11
关键词	Osteopontin CD44 Tissue microarray Hepatocellular carcinoma Prognosis
ISSN号	1083-7159
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4958428
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Yang, Guo-Huan,Fan, Jia,Xu, Yang,et al. Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection[J]. ONCOLOGIST,2008,13(11).
APA	Yang, Guo-Huan.,Fan, Jia.,Xu, Yang.,Qiu, Shuang-Jian.,Yang, Xin-Rong.,...&Zhou, Jian.(2008).Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection.ONCOLOGIST,13(11).
MLA	Yang, Guo-Huan,et al."Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection".ONCOLOGIST 13.11(2008).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。